PTC Therapeutics to Present Recent Data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium
- Results from the APHENITY trial in PKU and long-term extension study including Phe tolerance to be highlighted -
Source: eagletribune.com